These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22403182)

  • 1. Canakinumab induces remission in a patient with resistant familial Mediterranean fever.
    Hacihamdioglu DO; Ozen S
    Rheumatology (Oxford); 2012 Jun; 51(6):1041. PubMed ID: 22403182
    [No Abstract]   [Full Text] [Related]  

  • 2. Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study.
    Brik R; Butbul-Aviel Y; Lubin S; Ben Dayan E; Rachmilewitz-Minei T; Tseng L; Hashkes PJ
    Arthritis Rheumatol; 2014 Nov; 66(11):3241-3. PubMed ID: 25049046
    [No Abstract]   [Full Text] [Related]  

  • 3. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis.
    Mitroulis I; Skendros P; Oikonomou A; Tzioufas AG; Ritis K
    Ann Rheum Dis; 2011 Jul; 70(7):1347-8. PubMed ID: 21345814
    [No Abstract]   [Full Text] [Related]  

  • 5. Canakinumab as monotherapy for treatment of familial Mediterranean fever - first report in Central and Eastern Europe region.
    Jesenak M; Hrubiskova K; Kapustova L; Kostkova M; Banovcin P
    Bratisl Lek Listy; 2018; 119(4):198-200. PubMed ID: 29663815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.
    Laskari K; Boura P; Dalekos GN; Garyfallos A; Karokis D; Pikazis D; Settas L; Skarantavos G; Tsitsami E; Sfikakis PP
    J Rheumatol; 2017 Jan; 44(1):102-109. PubMed ID: 28042127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.
    Gül A; Ozdogan H; Erer B; Ugurlu S; Kasapcopur O; Davis N; Sevgi S
    Arthritis Res Ther; 2015 Sep; 17(1):243. PubMed ID: 26337145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment.
    Alpa M; Roccatello D
    Drug Des Devel Ther; 2015; 9():1983-7. PubMed ID: 25945034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1beta and the autoinflammatory diseases.
    Dinarello CA
    N Engl J Med; 2009 Jun; 360(23):2467-70. PubMed ID: 19494224
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of canakinumab in the cryopyrin-associated periodic syndrome.
    Lachmann HJ; Kone-Paut I; Kuemmerle-Deschner JB; Leslie KS; Hachulla E; Quartier P; Gitton X; Widmer A; Patel N; Hawkins PN;
    N Engl J Med; 2009 Jun; 360(23):2416-25. PubMed ID: 19494217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis.
    Kisla Ekinci RM; Balci S; Dogruel D; Altintas DU; Yilmaz M
    Paediatr Drugs; 2019 Oct; 21(5):389-395. PubMed ID: 31463794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients.
    Gülez N; Makay B; Sözeri B
    Mod Rheumatol; 2020 Jan; 30(1):166-171. PubMed ID: 30556769
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.
    Meinzer U; Quartier P; Alexandra JF; Hentgen V; Retornaz F; Koné-Paut I
    Semin Arthritis Rheum; 2011 Oct; 41(2):265-71. PubMed ID: 21277619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1beta-targeted antibody approved for rare autoinflammatory disorders.
    Nat Rev Drug Discov; 2009 Aug; 8(8):605. PubMed ID: 19644468
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of familial Mediterranean fever: colchicine and beyond.
    Gül A
    Isr Med Assoc J; 2014 May; 16(5):281-4. PubMed ID: 24979831
    [No Abstract]   [Full Text] [Related]  

  • 16. Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome.
    Torene R; Nirmala N; Obici L; Cattalini M; Tormey V; Caorsi R; Starck-Schwertz S; Letzkus M; Hartmann N; Abrams K; Lachmann H; Gattorno M
    Ann Rheum Dis; 2017 Jan; 76(1):303-309. PubMed ID: 27474763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canakinumab eliminates resistant familial Mediterranean fever in a Japanese girl.
    Yasuda R; Mizuochi T; Kitamura M; Migita K; Yamashita Y
    Pediatr Int; 2019 Nov; 61(11):1173-1174. PubMed ID: 31724243
    [No Abstract]   [Full Text] [Related]  

  • 18. Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
    Gattorno M; Obici L; Cattalini M; Tormey V; Abrams K; Davis N; Speziale A; Bhansali SG; Martini A; Lachmann HJ
    Ann Rheum Dis; 2017 Jan; 76(1):173-178. PubMed ID: 27269295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canakinumab in Schnitzler syndrome.
    Vanderschueren S; Knockaert D
    Semin Arthritis Rheum; 2013 Feb; 42(4):413-6. PubMed ID: 22901459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy.
    Sacré K; Brihaye B; Lidove O; Papo T; Pocidalo MA; Cuisset L; Dodé C
    J Rheumatol; 2008 Feb; 35(2):357-8. PubMed ID: 18260167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.